Medicine Supply · Mind Medicine Australia
Mind Medicine Australia logo Menu

Medicine Supply

Mind Medicine Australia has secured a supply agreement with Optimi Health for MDMA and psilocybin.

This agreement will ensure Australian psychiatrists and researchers have affordable access to GMP grade medicines for clinical trials and the TGA’s Authorised Prescriber Scheme, which begins from July 1st 2023.

Read Optimi Health’s press release for more details here.

Additionally, we are able to supply MDMA and psilocybin  at no cost for innovative clinical trials.

Registered health professionals and researchers are invited to fill out the EOI form below, and a member of our team will reach out to provide further details.

Subscribe to our newsletter

Stay in touch with Mind Medicine Australia: